Viralgen at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Viralgen brings 4 presentations to ESGCT 2026 in Hamburg. Its contributions centre on recombinant AAV production and quality, from in-line capacitance probes and added synthetic molecules that raise yield to small-scale studies of vector stability under stress. A further strand measures the repeatability of a long-read sequencing assay for genome integrity.
| Organization | ESGCT 2026 Attendance |
|---|---|
Viralgen San Sebastián, Spain | |
AAV contract manufacturer offering process development and GMP vector production, part of Bayer's AskBio. | Poster Wed Oct 28 1:30pm–3:30pm In-line Capacitance Probes Enable Enhanced and Consistent High-Quality rAAV Manufacturing Poster Wed Oct 28 1:30pm–3:30pm Optimization of recombinant Adeno-Associated Virus vector production: Integrating synthetic molecules to enhance vector yield and quality for clinical gene therapy applications Poster Wed Oct 28 1:30pm–3:30pm Repeatability and intermediate precision of a genome integrity assay for rAAV by long-read sequencing Manufacturing, CMC and access Poster Thu Oct 29 2:00pm–4:00pm Investigations of AAV stability under stress conditions using small-scale models |
Instantly find 20 buyers from Viralgen
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction